Type 2 Diabetes
PhytoMedical Continues to Strengthen Research and Development Team with Key Appointment
Published in Food and Drug Law Weekly, April 13th, 2007
"I'm very pleased with the addition of Dr. Mark Bossie to the PhytoMedical team," commented PhytoMedical President and CEO, Mr. Greg Wujek. "Mark's very special expertise with novel pharmaceutical compounds is particularly helpful as we work towards expanding the Company's drug discovery pipeline, while continuing to move our new class of compounds for type-2 diabetes towards an Investigative New Drug application with the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Drug Development
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs - Keratitis
Burg Simpson Files Lawsuit Against Bausch & Lomb for a Man Who Contracted Fusarium Keratitis After Using ReNu With MoistureLoc - Regulatory Actions
CalPERS Calls on Members of the U.S. House of Representatives to Preserve Access to Safe, Affordable Generics - Regulatory Actions
International Aid Names Robert J. Goodwin Chief Operating Officer - Anthrax
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection - Anthrax Vaccines
Centers for Disease Control and Prevention details research in anthrax vaccines - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
